Outcome of Board meeting approving issue of 1000000 equity shares on preferential issue basis.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
07-Mar-2026
Download PDF
Neogen Chemicals
Outcome of Board meeting approving issue of 1000000 equity shares on preferential issue basis.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]